Compile Data Set for Download or QSAR
Found 183 Enz. Inhib. hit(s) with all data for entry = 7700
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212110(US9290485, 142)copy SMILEScopy InChI
Affinity DataIC50: 0.0224nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212116(US9290485, 148)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212114(US9290485, 146)copy SMILEScopy InChI
Affinity DataIC50: 0.0400nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM211977(US9290485, 9)copy SMILEScopy InChI
Affinity DataIC50: 0.0912nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212115(US9290485, 147)copy SMILEScopy InChI
Affinity DataIC50: 0.100nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212136(US9290485, 168)copy SMILEScopy InChI
Affinity DataIC50: 0.100nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212004(US9290485, 36)copy SMILEScopy InChI
Affinity DataIC50: 0.134nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM211974(US9290485, 6)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212134(US9290485, 166)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212135(US9290485, 167)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212113(US9290485, 145)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212141(US9290485, 173)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212124(US9290485, 156)copy SMILEScopy InChI
Affinity DataIC50: 0.920nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212109(US9290485, 141)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212125(US9290485, 157)copy SMILEScopy InChI
Affinity DataIC50: 2nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212122(US9290485, 154)copy SMILEScopy InChI
Affinity DataIC50: 2nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212062(US9290485, 94)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212111(US9290485, 143)copy SMILEScopy InChI
Affinity DataIC50: 2.60nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212137(US9290485, 169)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212123(US9290485, 155)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212043(US9290485, 75)copy SMILEScopy InChI
Affinity DataIC50: 3.10nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212083(US9290485, 115)copy SMILEScopy InChI
Affinity DataIC50: 3.30nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212120(US9290485, 152)copy SMILEScopy InChI
Affinity DataIC50: 4nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212126(US9290485, 158)copy SMILEScopy InChI
Affinity DataIC50: 4nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212129(US9290485, 161)copy SMILEScopy InChI
Affinity DataIC50: 4nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212108(US9290485, 140)copy SMILEScopy InChI
Affinity DataIC50: 4.60nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212107(US9290485, 139)copy SMILEScopy InChI
Affinity DataIC50: 4.90nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212131(US9290485, 163)copy SMILEScopy InChI
Affinity DataIC50: 5nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212130(US9290485, 162)copy SMILEScopy InChI
Affinity DataIC50: 5nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212057(US9290485, 89)copy SMILEScopy InChI
Affinity DataIC50: 6nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212133(US9290485, 165)copy SMILEScopy InChI
Affinity DataIC50: 6nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212127(US9290485, 159)copy SMILEScopy InChI
Affinity DataIC50: 7nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212117(US9290485, 149)copy SMILEScopy InChI
Affinity DataIC50: 7.80nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212008(US9290485, 40)copy SMILEScopy InChI
Affinity DataIC50: 9nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM211991(US9290485, 23)copy SMILEScopy InChI
Affinity DataIC50: 9nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212099(US9290485, 131)copy SMILEScopy InChI
Affinity DataIC50: 9nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212138(US9290485, 170)copy SMILEScopy InChI
Affinity DataIC50: 9.70nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212118(US9290485, 150)copy SMILEScopy InChI
Affinity DataIC50: 10nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212031(US9290485, 63)copy SMILEScopy InChI
Affinity DataIC50: 11nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212119(US9290485, 151)copy SMILEScopy InChI
Affinity DataIC50: 13nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212032(US9290485, 64)copy SMILEScopy InChI
Affinity DataIC50: 14nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212095(US9290485, 127)copy SMILEScopy InChI
Affinity DataIC50: 16nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212121(US9290485, 153)copy SMILEScopy InChI
Affinity DataIC50: 16nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212051(US9290485, 83)copy SMILEScopy InChI
Affinity DataIC50: 18nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM211994(US9290485, 26)copy SMILEScopy InChI
Affinity DataIC50: 19nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212006(US9290485, 38)copy SMILEScopy InChI
Affinity DataIC50: 19nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212128(US9290485, 160)copy SMILEScopy InChI
Affinity DataIC50: 20nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM211995(US9290485, 27)copy SMILEScopy InChI
Affinity DataIC50: 21nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212104(US9290485, 136)copy SMILEScopy InChI
Affinity DataIC50: 24nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM212139(US9290485, 171)copy SMILEScopy InChI
Affinity DataIC50: 26nMpH: 7.8 T: 2°CAssay Description:Enzymatic reactions were conducted in ⿿assay buffer⿿, comprising 50 mM Hepes/NaOH at pH 7.8, 150 mM NaCl, 1 mM EDTA and 0.05% (w/v) CHAPS. For th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26H4G73US Patent
Displayed 1 to 50 (of 183 total ) | Next | Last >>
Jump to: